Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sandoz - hydroxycarbamide - gélule - 500 mg - composition pour une gélule > hydroxycarbamide : 500 mg - autres antinéoplasiques

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sandoz - hydroxycarbamide - gélule - 500 mg - composition pour une gélule > hydroxycarbamide : 500 mg - autres antineoplasiques

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - hydroxycarbamide (hydroxyurea), quantity: 500 mg - capsule, hard - excipient ingredients: erythrosine; titanium dioxide; lactose monohydrate; gelatin; citric acid; quinoline yellow; magnesium stearate; indigo carmine; dibasic sodium phosphate; sodium lauryl sulfate - significant tumour response to hydroxycarbamide (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

devatis limited - hydroxycarbamide 500mg;  ;   - capsule - 500 mg - active: hydroxycarbamide 500mg     excipient: citric acid dibasic sodium phosphate erythrosine gelatin indigo carmine lactose monohydrate magnesium stearate quinoline yellow titanium dioxide - significant tumor response to hydroxycarbamide (hydroxyurea) has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent metastatic or inoperable carcinoma of the ovary. hydroxycarbamide used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip, and carcinoma of the cervix.

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

bmodesto b.v. minervaweg 2 8239 dl lelystad - hydroxycarbamide 500 mg/stuk - capsule, hard - ammonia (e 527) ; citroenzuur 0-water (e 330) ; dinatriumwaterstoffosfaat 0-water (e 339) ; erythrosine (e 127) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; indigokarmijn (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak glaze, gedeeltelijk veresterd ; titaandioxide (e 171) ; zwarte inkt

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

hydroxycarbamide 500 mg/stuk - capsule, hard - ammonia (e 527) ; citroenzuur 0-water (e 330) ; dinatriumwaterstoffosfaat 0-water (e 339) ; erythrosine (e 127) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; indigokarmijn (e 132) ; lactose 0-water ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak glaze, gedeeltelijk veresterd ; titaandioxide (e 171) ; zwarte inkt

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

hydroxycarbamide 500 mg/stuk - capsule, hard - chinolinegeel (e 104) ; citroenzuur 0-water (e 330) ; dinatriumwaterstoffosfaat 0-water (e 339) ; erythrosine (e 127) ; gelatine (e 441) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; titaandioxide (e 171)

Malta - engelsk - Medicines Authority

pharmachemic trading agency company limited - hydroxycarbamide - hard capsule - hydroxycarbamide 500 milligram(s) - antineoplastic agents

Malta - engelsk - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - hydroxycarbamide - hard capsule - hydroxycarbamide 500 mg - antineoplastic agents

Kenya - engelsk - Pharmacy and Poisons Board

sandoz gmbh kundl biochemiestrasse 106250, austria - hydroxycarbamide - capsule, hard - 500mg - hydroxycarbamide